I am not sure, what they mean by "Ongoing". You can find out the status of any trial on clinicaltrials.gov.
All I know is that Imugene have seven trials on there (clinicaltrials.gov) and four of them are Active, not recruiting (including PD1-VAxx) This means they are no longer recruiting patients for the trial. Of course this may change (hence the word active), however at the moment they are not getting any new patients in. For all practical purposes this seems "on hold".
Summary is... (fits with the prioritisation of Azer-Cel/Oncar/CF33)
Axer-Cel - Active/recruiting.
Oncarlytics with Blinatuomab - Active/recruiting.
Vaxinia (MAST) - Active/recruiting.
HerVaxx NextHerizon - Active/ not recruiting.
Pd1Vaxx - Imprinter - Active/ not recruiting.
Hervaxx GC - Active/ not recruiting.
Cf33 / Checkvacc - Active/ not recruiting.
You can see it here on this link - just search imugene.
https://clinicaltrials.gov/search?term=imugene
DYOR and all that,
- Forums
- ASX - By Stock
- Why IMU is a multi multi bagger
I am not sure, what they mean by "Ongoing". You can find out the...
-
-
- There are more pages in this discussion • 703 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M |
Open | High | Low | Value | Volume |
5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1921794 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 1368288 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 286362 | 0.055 |
9 | 2036888 | 0.054 |
16 | 2736044 | 0.053 |
20 | 1943436 | 0.052 |
23 | 3206056 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 378902 | 2 |
0.058 | 1552127 | 7 |
0.059 | 837099 | 8 |
0.060 | 2176188 | 16 |
0.061 | 1163926 | 6 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online